ASTL ASPARTATE AMINOTRANSFERASE - PYRIDOXAL PHOSPHATE ACTIVATED 20764949322

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2017-06-16 for ASTL ASPARTATE AMINOTRANSFERASE - PYRIDOXAL PHOSPHATE ACTIVATED 20764949322 manufactured by Roche Diagnostics.

Event Text Entries

[77846336] (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[77846337] The customer received questionable astl aspartate aminotransferase results for one patient sample. The initial result was 62 u/l with a data flag indicating a high absorbance value. The automatic repeat result was 66 u/l which was auto-verified and reported outside the laboratory. There were flags on other results for the same sample indicating hemolysis. The customer questioned why the initial ast result did not also have the flag indicting hemolysis. It was explained to the customer that only one flag is displayed and the flag indicating the high absorbance value overrides the hemolysis flag. The patient was discharged and was then redrawn on (b)(6) 2017. The ast result was 39 u/l. The patient was redrawn on (b)(6) 2017 and the ast result was 45 u/l. The customer then believed the reported result of 66 u/l to be incorrect. The customer thought the hemolysis had some impact on the result, but did not think it was enough to be clinically significant. The patient was not adversely affected. The customer declined a service visit. The customer used cobas 6000 c (501) module serial number (b)(4).
Patient Sequence No: 1, Text Type: D, B5


[132606446] The investigation confirmed the analyzer flagged the results as appropriate. There was no malfunction of the device. An issue with the sample was detectable as the hemolysis index result of 280 was visible to the customer. Per product labeling for the assay, there is no significant interference only up to a hemolysis index of 40. The interference of the hemolysis caused the high result.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-01245
MDR Report Key6646129
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2017-06-16
Date of Report2017-07-27
Date of Event2017-05-19
Date Mfgr Received2017-05-26
Date Added to Maude2017-06-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameASTL ASPARTATE AMINOTRANSFERASE - PYRIDOXAL PHOSPHATE ACTIVATED
Generic NameNADH OXIDATION/NAD REDUCTION, AST/SGOT
Product CodeCIT
Date Received2017-06-16
Model NumberNA
Catalog Number20764949322
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-06-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.